Oligosaccharide receptors for bacteria: A view to a kill

Current Opinion in Chemical Biology

Volumn 2, Issue 6, 1998, Pages 695-700

  Lingwood, Clifford A ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CELL SURFACE RECEPTOR; OLIGOSACCHARIDE;

BACTERIUM; CARBOHYDRATE METABOLISM; DRUG EFFECT; METABOLISM; REVIEW;

ANTI-BACTERIAL AGENTS; BACTERIA; CARBOHYDRATE METABOLISM; OLIGOSACCHARIDES; RECEPTORS, CELL SURFACE;

EID: 0032239313     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(98)80105-1     Document Type: Article

References (57)

1. Beachey EH: Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surfaces. J Infect Dis 1981, 143:325-345.
2. Finlay B, Cossart P: Exploitation of mammalian host cell functions by bacterial pathogens. Science 1997, 276:718-725.
3. Hoepelman AIM, Tuomanen EI: Consequences of microbial attachment: Directing host cell functions with adhesins. Infect Immun 1992, 60:1729-1733.
4. Svensson M, Lindstedt R, Radin NS, Svanborg C: Epithelial glycosphingolipid expression as a determinant of bacterial adherence and cytokine production. Infect Immun 1994, 62:4404-4410.
5. Ismaili A, Philpott D, Dytoc MT, Shermann PM: Signal transduction responses following adhesion of verotoxin-producing Escherichia coli. Infect Imumun 1995, 63:3316-3326.
6. Segal E, Lange C, Covacci A, Tompkins L, Falkow S: Induction of host signal transduction pathways by Helicobacter pylori. Proc Natl Acad Sci USA 1997, 94:7595-7599. This paper investigates several signal transduction pathways that are activated following H. pylori attachment and shows that the host-cell response is dependent on the Cag pathogenicity island of type 1 strains associated with symptomatic infection.
7. Parsonnet J, Friedman G, Vandersteen D, Chang Y, Vogelman J, Orentreich N, Sibley R: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991, 325:1127-1131.
8. Nomura A, Stemmermann GN, Chyou P-H, Kato I, Perez-Perez G, Blaser MJ: Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991, 325:1132-1136.
9. Cheli R, Crespi M, Testino G, Citarda F: Gastric cancer and Helicobacter pylori: biologic and epidemiologic inconsistencies. J Clin Gastroenterol 1998, 26:3-6.
10. Wilkinson SM, Uhl JR, Kline BC, Cockerill FR III: Assessment of invasion frequencies of cultured HEp-2 cells by clinical isolates of Helicobacter pylori using an acridine orange assay. J Clin Pathol 1998, 51:127-133.
11. Karlsson KA: Animal glycosphingolipids as membrane attachment sites for bacteria. Annu Rev Biochem 1989, 58:309-350.
12. Merrill A, Hannun Y, Bell R: Sphingolipids and their metabolites in cell regulation. In Sphingolipids Part A: Functions and Breakdown Products. Edited by Bell R, Hannun Y, Merrill A. San Diego: Academic Press; 1993:1-24.
13. Ångstrom J, Teneberg S, Milh MA, Larsson T, Leonardsson I, Olsson B-M, Halvarsson MO, Danielsson D, Naslund I, Ljungh A, Wadstrom T, Karlsson K-A: The lactosylceramide binding specificity of Helicobacter pylori. Glycobiology 1998, 8:297-309. Only a subpopulation of lactosyl ceramide species containing hydroxy fatty acids and hydroxy sphingosine are recognized by H. pylori, further supporting the importance of the lipid moiety in determining bacterial binding of glycolipids.
14. Stromberg N, Ryd M, Lindburg AA, Karlsson KA: Studies on the binding of bacteria to glycolipids: two species of Propionibacterium apparently recognize separate epitopes on lactose of lactosylceramide. FEBS Lett 1988, 232:193-198.
15. Tomb J-F, White O, Kerlavage AR, Clayton RA, Sutton GG, Heischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA et al.: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997, 388:539-547. Mammoth work in DNA sequencing was carried out and described here, which provides clues as to the importance of adherence in H. pylori infection.
16. Lingwood CA, Wasfy G, Han H, Huesca M: Receptor affinity purification of a lipid-binding adhesin from Helicobacter pylori. Infect Immun 1993, 61:2474-2478.
17. Miller-Podraza H, Milh MA, Bergström J, Karlsson K-A: Recognition of glycoconjugates by Helicobacter pylori: an apparently high-affinity binding of human polyglycosylceramides, a second sialic acid-based specificity. Glycoconj J 1996, 13:453-460.
18. Borén T, Falk P, Roth KA, Larson G, Normark S: Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993, 262:1892-1895.
19. b-binding adhesin.
20. Weel J, van der Hulst RW, Gerrits Y, Roorda P, Feller M, Dankert J, Tytgat GN, van der Ende A: The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis 1996, 173:1171-1175.
21. b-containing glycoconjugates: a potential transgenic mouse model for studying Helicobacter pylon infection. Proc Natl Acad Sci USA 1995,92:1515-1519.
22. Guruge JL, Falk PG, Lorenz RG, Dans M, Wirth H-P, Blaser MJ, Berg DE, Gordon JI: Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci USA 1998, 95:3925-3930. This work establishes a mouse model of H. pylori infection and demonstrates the crucial role of binding to Lewisb glycoconjugates in the induction of gastric pathology via an autoimmune mechanism.
23. Sherburne R, Taylor DE: Helicobacter pylori expresses a complex surface carbohydrate, Lewis X. Infect Immun 1995, 63:4564-4568.
24. Appelmelk BJ, Simoons-Smit I, Negrini R, Moran AP, Aspinall GO, Forle JG, DeVries T, Quan H, Verboom T, Maaskant JJ et al.: Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun 1996, 64:2031-2040.
25. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Issacson PG: Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993, 342:575-577.
26. ••]).
27. Namavar F, Sparrius M, Veerman E, Appelmelk B, Vandenbroucke-Grauls C: Neutrophil-activating protein mediates adhesion of Helicobacter pylori to sulfated carbohydrates on high-molecular-weight salivary mucin. Infect Immun 1998, 66:444-447. Affinity chromatography shows that neutrophil-activating protein (NAP) mediates the binding of H. pylori to sulfated oligosaccharides in oral mucin. This is an unexpected function for NAP (as NAP was previously known to be a soluble protein, with no role in adhesion).
28. Veerman EC, Bank CM, Namavar F, Appelmelk BJ, Bolscher JG, Nieuw Amerongen AV: Sulfated glycans on oral mucin as receptors for Helicobacter pylori. Glycobiology 1997, 7:737-743.
29. Teneberg S, Miller-Podraza H, Lampert HC, Evans DJ Jr, Evans DG, Danielsson D, Karlsson K-A: Carbohydrate binding specificity of the neutrophil-activating protein of Helicobacter pylori. J Biol Chem 1997, 272:19067-19071. The sulfated-carbohydrate binding specificity of neutrophil-activating protein (NAP) is established. Although sulfatide is found to be a major ligand, this glycolipid is not found in neutrophils, suggesting that NAP may have additional functions.
30. Aruffo A, Kolanus W, Walz G, Fredman P, Seed B: CD62/P-Selectin recognition of myeloid and tumor cell sulfatides. Cell 1991, 67:35-44.
31. x oligosaccharides and the predominance of sulfate in this interaction demonstrated by binding studies with a series of lipid-linked oligosaccharides. Biochem Biophys Res Commun 1992, 188:244-251.
32. a. J Biol Chem 1994, 269:1595-1598.
33. Lingwood CA: Aglycone modulation of glycolipid receptor function. Glycoconj J 1996,13:495-503.
34. Simon PM, Goode PL, Mobasseri A, Zopf D: Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides. Infect Immun 1997, 65:750-757. The efficacy of multimeric 3′-sialyl-lactose in the inhibition of H. pylori binding to epithelial cells is demonstrated. In addition, bacteria that are already bound can be removed by this treatment.
35. Barthelson R, Mobasseri A, Zopf D, Simon P: Adherence of Streptococcus pneumoniae to respiratory epithelial cells is inhibited by sialated oligosaccharides. Infect Immun 1998, 66:1439-1444. This is the first report of sialyl requirement for binding. A major increase in sugar inhibition of bacterial-epithelial cell adhesion using a polyvalent analog is described.
36. Cundell DR, Tuomanen EI: Receptor specificity of adherence of Streptococcus pneumoniae to human type-11 pneumocytes and vascular endothelial cells in vitro. Microb Pathog 1994, 17:361-374.
37. Idänpään-Heikkilä I, Simon PM, Zopf D, Vullo T, Cahill P, Sokol K, Tuomanen E: Oligosaccharides interfere with the establishment and progression of experimental pneumococcal pneumonia. J Infect Dis 1997, 176:704-712. This paper describes the in vivo therapeutic efficacy of oligosaccharide analogs.
38. Pagé D, Roy R: Synthesis and biological properties of mannosylated starburst poly(amidoamine) dendrimers. Bioconj Chem 1997, 8:714-723. This paper describes a new spherical dendrimer format for the generation of soluble polyvalent oligosaccharide receptor analogs.
39. Roy R, Pagé D, Perez SF, Bencomo VV: Effect of shape, size, and valency of multivalent mannosides on their binding properties to phytohemagglutinins. Glycoconj J 1998, 15:251-263.
40. Kang B, Schlesinger L: Characterization of mannose dependent phagocytosis mediated by Mycobacterium tuberculosis lipoarabinomannan. Infect Immun 1998, 66:2769-1777.
41. Swanson A, Ezekowitz R, Lee A, Kuo C: Human mannose binding protein inhibits infection of HeLa cells by Chlamydia trachomatis. Infect Immun 1998, 66:1607-1612.
42. Mortell K, Weatherman R, Kiessling L: Recognition specificity of neoglycopolymers by ring-opening metathesis polymerization. J Am Chem Soc 1996, 118:2297-2298.
43. Manning D, Hu X, Beck P, Kiessling L: Synthesis of neoglycopolymers: selective P-selectin inhibitors. J Am Chem Soc 1997, 119:3161-3162.
44. x which biologically mimic the presentation of the L-selectin epitope on cell surface mucin-type glycoproteins.
45. Galustian C, Childs RA, Yuen CT, Hasegawa A, Kiso M, Lubineau A, Shaw G, Feizi T: Valency dependent patterns of binding of human L-selectin towards sialyl and sulfated oligosaccharides of Le(a) and Le(x) types: relevance to anti-adhesion therapeutics. Biochemistry 1997, 36:5260-5266.
46. Saukkonen K, Burnette WN, Mar VL, Masure HR, Tuomanen EI: Pertussis toxin has eukaryotic-like carbohydrate recognition domains. Proc Natl Acad Sci USA 1992, 89:118-122.
47. Sandros J, Rozdzinski E, Zheng J, Cowburn D, Tuomanen E: Lectin domains in the toxin of Bordetella pertussis: selectin mimicry linked to microbial pathogenesis. Glycoconj J 1994, 11:501-506.
48. Kanai M, Mortel K, Kiessling L: Varying the size of multivalent ligands: the dependence of Concanavalin A binding on neoglycopolymer length. J Am Chem Soc 1997, 119:9931-9932.
49. Hansen H, Haataja S, Finne J, Magnusson G: Di-,tri and tetravalent galabiosides that inhibit hemagglutination by Streptococcus suis at nanomolar concentrations. J Am Chem Soc 1997, 119:6974-6979. New chemistry is described for the generation of divalent, trivalent and tetravalent galabiose receptor analogs. Relative positioning of the galabiose 'units' causes major differences in bacterial anti-adhesive activity.
50. Evans DG, Evans DJ, Moulds JJ, Graham DY: N-acetylneuraminyl lactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect Immun 1988, 56:2896-2906.
51. Evans D, Karjalainen T, Evans D, Graham D, Lee C-H: Cloning, nucleotide sequence, and expression of an adhesin subunit protein of Helicobacter pylori. J Bacteriol 1993, 175:674-683.
52. Lingwood CA, Huesca M,Kuksis A: The glycerolipid receptor for Helicobacter pylori (and exoenzyme S) is phosphatidylethanolamine. Infect Immun 1992, 60:2470-2474.
53. Saitoh T, Sugano K, Natomi H, Zhao W, Okuzumi K, Iwamori M, Yazaki Y: Glycosphingolipid receptors in human gastric mucosa for Helicobacter pylori. Eur J Gastroenterol Hepatol 1992, 4:S49-S53.
54. Kamisago S, Iwamori M, Tai T, Mitamura K, Yazaki Y, Sugano K: Role of sulfatides in adhesion of Helicobacter pylori to gastric cancer cells. Infect Immun 1996, 64:624-628.
55. Huesca M, Borgia S, Huffman P, Lingwood CA: Acidic pH changes receptor binding of Helicobacter pylori: a binary adhesion model in which surface heat-shock (stress) proteins mediate sulfatide recognition in gastric colonization. Infect Immun 1996, 64:2643-2648.
56. Wadstrom T, Hirmo S, Novak H, Guzman A, Ringner-Pantzar M, Utt M, Aleljung A: Sulfatides inhibit binding of Helicobacter pylori to gastric cancer Kato III cell line. Curr Microbiol 1997, 34:267-272.
57. Chmiela M, Paziak-Domanska B, Rudnicka W, Wadström T: The role of heparan sulphate-binding activity of Helicobacter pylori bacteria in their adhesion to murine macrophages. Acta Pathol Microbiol Immunol Scand [B] 1995, 103:469-474.